Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbolica (RIETE) registry

Registro Informatizado, Jaime Borjas Howard*, Pablo Ruiz-Sada, Karina de Leeuw, Luciano Lopez-Jimenez, Carme Font, Pablo Javier Marchena, Olga Madridano, Philippe Debourdeau, Karina Meijer, Manuel Monreal

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

6 Downloads (Pure)


Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03-1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks.

Originele taal-2English
Aantal pagina's5
TijdschriftBritish Journal of Haematology
StatusE-pub ahead of print - 2-jun-2021

Citeer dit